Effect of a single aspirin dose prior to fecal immunochemical testing on test sensitivity for detecting advanced colorectal neoplasms. A randomized clinical trial. JAMA 2019; 321: 1686-1692.
Published: 18th July 2019
Authors: Brenner H, Calderazzo S, Seufferlein T, Ludwig L, Dikopoulos N, Mangold J et al.
In this trial that included 2422 subjects, a single dose of 300mg aspirin taken two days before faecal immunohistochemical sampling did not affect the sensitivity of the test.Pubmed Link
You may also be interested in
Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion. A randomized clinical trial. JAMA 2017; 318: 806-815.
Authors: Singal AG, Gupta S, Skinner CS, Ahn C, Santini NO, Agrawal D et al.
Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. Lancet 2017; 389: 1299–1311.
Authors: Atkin W , Wooldrage K, Parkin DM, Kralj-Hans I, MacRae E, Shah U et al.
Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ 2017; 356: i6673.
Authors: Holme Ø , Schoen RE, Senore C, Segnan N, Hoff G, Løberg M et al.
Randomized comparison of surveillance intervals in familial colorectal cancer. J Clin Oncol 2015; 33: 4188-4193.
Authors: Hennink SD, van Der Meulen-de Jong AE, Wolterbeek R, Crobach ASLP, Becx MCJM, Crobach WSFJ et al. et al.
Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials. Lancet 2016; 387: 751-759.
Authors: Wardle J, von Wagner C, Kralj-Hans I, Halloran SP, Smith SG, McGregor LM et al. et al.
Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014; 348: g2467.
Authors: Brenner H, Stock C, Hoffmeister M
Authors: Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS et al. et al.
Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomised controlled trials. Plos MED 2012; 9: e1001352.
Authors: Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK et al.
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012; 366: 2345–2357.
Authors: Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO et al. et al.
Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012; 61: 1036–1040.
Authors: Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD
Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial – SCORE. J Natl Cancer Inst 2011; 103: 1310–1322.
Authors: Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M et al. et al.
Screening for colorectal cancer: randomised trial comparing guiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59: 62-68.
Authors: Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JCIY et al. et al.